MedPath

DAIVOBET

Brand Name: DAIVOBET

Generic Name: Calcipotriol (as Monohydrate) + Betamethasone (as dipropionate)

Active
Registration Number

DR-XY41745

Dosage Form

Topical Gel

Issuance Date

October 27, 2024

Expiry Date

January 21, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mcg/500 mcg per gram
PackagingHDPE Bottle x 15 g, 30 g and 60 g (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-psoriais
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Calcipotriol (as Monohydrate)Active
Monograph: calcipotriol (as monohydrate)
Betamethasone (as dipropionate)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform